← Open Payments lookup

MATTHEW BALDUS: Open Payments

NPI 1164197190 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,250 in 63 payments from 18 companies in 2025. Trend: 2023 $1,265 · 2024 $1,700 · 2025 $1,250

Food & beverage: $1,250
CompanyPaymentsAmount
ABBVIE INC.15$256
Ardelyx, Inc.6$147
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$139
Janssen Biotech, Inc.6$137
Madrigal Pharmaceuticals4$107
GENZYME CORPORATION3$93
Takeda Pharmaceuticals U.S.A., Inc.2$54
Lilly USA, LLC2$49
Ipsen Biopharmaceuticals, Inc2$45
Novo Nordisk Inc2$43

Products named: IBSRELA, TREMFYA, DUPIXENT, RINVOQ, XIFAXAN, REZDIFFRA, LINZESS, ENTYVIO.

Industry payments across AZ — which companies pay providers there.